Advertisement
Singapore markets close in 3 hours 40 minutes
  • Straits Times Index

    3,286.75
    -1.00 (-0.03%)
     
  • Nikkei

    38,044.58
    +416.10 (+1.11%)
     
  • Hang Seng

    17,608.69
    +324.15 (+1.88%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Bitcoin USD

    64,224.48
    +59.53 (+0.09%)
     
  • CMC Crypto 200

    1,384.36
    +1.79 (+0.13%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,347.40
    +4.90 (+0.21%)
     
  • Crude Oil

    83.88
    +0.31 (+0.37%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,573.86
    +4.61 (+0.29%)
     
  • Jakarta Composite Index

    7,115.99
    -39.31 (-0.55%)
     
  • PSE Index

    6,571.10
    -3.78 (-0.06%)
     

Why Dynavax Crushed the Market on Thursday

Biotech Dynavax Technologies (NASDAQ: DVAX) had a terrific Thursday on the stock market. Thursday morning, Valneva announced that the committee for medicinal products for human use (CHMP) advising the European Medicines Agency (EMA) has recommended the jab be granted marketing authorization as a primary shot for adults 18 to 50 years old. The next step is for the European Commission (EC) to review the CHMP's recommendation and make a decision.